Nordea Investment Management AB Purchases 2,300 Shares of GE HealthCare Technologies Inc. $GEHC

Nordea Investment Management AB increased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.1% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 46,972 shares of the company’s stock after purchasing an additional 2,300 shares during the quarter. Nordea Investment Management AB’s holdings in GE HealthCare Technologies were worth $3,488,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Hotchkis & Wiley Capital Management LLC lifted its position in GE HealthCare Technologies by 3.2% in the first quarter. Hotchkis & Wiley Capital Management LLC now owns 5,751,773 shares of the company’s stock worth $464,226,000 after purchasing an additional 176,572 shares during the period. JPMorgan Chase & Co. lifted its position in GE HealthCare Technologies by 49.9% in the first quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock worth $414,894,000 after purchasing an additional 1,711,963 shares during the period. Dimensional Fund Advisors LP lifted its position in GE HealthCare Technologies by 3.3% in the first quarter. Dimensional Fund Advisors LP now owns 4,943,579 shares of the company’s stock worth $398,975,000 after purchasing an additional 157,839 shares during the period. Canada Pension Plan Investment Board lifted its position in GE HealthCare Technologies by 15.2% in the first quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock worth $251,121,000 after purchasing an additional 409,636 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its position in GE HealthCare Technologies by 3.7% in the first quarter. Charles Schwab Investment Management Inc. now owns 3,069,114 shares of the company’s stock worth $247,708,000 after purchasing an additional 109,858 shares during the period. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC opened at $76.10 on Wednesday. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The firm has a market cap of $34.74 billion, a PE ratio of 15.59, a price-to-earnings-growth ratio of 2.88 and a beta of 1.13. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16. The business has a fifty day moving average of $74.60 and a 200-day moving average of $72.16.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The company had revenue of $5 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same period last year, the company posted $1.00 earnings per share. The firm’s quarterly revenue was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be paid a $0.035 dividend. The ex-dividend date is Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.87%.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on GEHC. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Morgan Stanley set a $74.00 price objective on GE HealthCare Technologies in a report on Thursday, September 18th. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Tuesday, October 14th. Citigroup cut GE HealthCare Technologies from a “buy” rating to a “neutral” rating and cut their price objective for the company from $93.00 to $83.00 in a report on Tuesday, October 7th. Finally, Barclays began coverage on GE HealthCare Technologies in a report on Monday, October 13th. They set an “equal weight” rating and a $86.00 price objective for the company. Six analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $85.20.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.